United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - calcium lactate; calcium phosphate; ergocalciferol - oral tablet - 300mg ; 150mg ; 10microgram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alissa healthcare research ltd - calcium lactate; calcium phosphate; ergocalciferol - oral tablet - 300mg ; 150mg ; 10microgram

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - calcium folinate, quantity: 10.8 mg/ml (equivalent: folinic acid, qty 10 mg/ml) - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; sodium chloride; water for injections - leucovorin calcium injection usp is indicated following high dose methotrexate therapy to reduce toxicity (leucovorin rescue). it is also indicated after inadvertent overdosage with methotrexate and in impaired methotrexate elimination.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - calcium folinate, quantity: 10.8 mg/ml (equivalent: folinic acid, qty 10 mg/ml) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; sodium chloride; hydrochloric acid - leucovorin calcium injection usp is indicated following high dose methotrexate therapy to reduce toxicity (leucovorin rescue). it is also indicated after inadvertent overdosage with methotrexate and in impaired methotrexate elimination.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - calcium folinate, quantity: 16.2 mg (equivalent: folinic acid, qty 15 mg) - injection, solution - excipient ingredients: sodium chloride; water for injections - leucovorin calcium has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions. leucovorin calcium has also shown good results in reducing the toxicity and circumventing the effect of folic acid antagonists, if therapeutically desired

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nutrien ag solutions limited - calcium as calcium borogluconate - parenteral liquid/solution/suspension - calcium as calcium borogluconate mineral-calcium active 29.7 g/l - nutrition & metabolism - cattle | sheep | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | ewe | heifer | h - milk fever

Canada - English - Health Canada

nu skin international, inc. - vitamin a (retinol palmitate); beta-carotene; ascorbic acid (calcium ascorbate); vitamin d (cholecalciferol); vitamin e (d-alpha tocopheryl acid succinate, mixed tocopherols); vitamin b1 (thiamine mononitrate); vitamin b2 (riboflavin, riboflavin-5-phosphate); nicotinamide; vitamin b6 (pyridoxine hydrochloride, pyridoxal-5-phosphate); vitamin b12 (cyanocobalamin); folic acid; biotin; d-pantothenic acid (calcium d-pantothenate); calcium (calcium carbonate, calcium hvp chelate, calcium citrate); iron (iron hvp chelate); magnesium (magnesium hvp chelate, magnesium oxide, magnesium citrate); zinc (zinc hvp chelate); copper (copper hvp chelate); chromium (chromium hvp chelate); manganese (manganese hvp chelate); iodine (potassium iodide); selenium (yeast (living cells)); molybdenum (molybdenum citrate) - capsule - 2500unit; 5000unit; 250mg; 200unit; 150unit; 1.5mg; 1.7mg; 20mg; 3mg; 9mcg; 0.3mg; 150mcg; 15mg; 166.7mg; 0.667mg; 83.33mg; 2.5mg; 0.33mg; 33.33mcg; 0.583mg; 0.0125mg; 16.66mcg; 8.33mcg - vitamin a (retinol palmitate) 2500unit; beta-carotene 5000unit; ascorbic acid (calcium ascorbate) 250mg; vitamin d (cholecalciferol) 200unit; vitamin e (d-alpha tocopheryl acid succinate, mixed tocopherols) 150unit; vitamin b1 (thiamine mononitrate) 1.5mg; vitamin b2 (riboflavin, riboflavin-5-phosphate) 1.7mg; nicotinamide 20mg; vitamin b6 (pyridoxine hydrochloride, pyridoxal-5-phosphate) 3mg; vitamin b12 (cyanocobalamin) 9mcg; folic acid 0.3mg; biotin 150mcg; d-pantothenic acid (calcium d-pantothenate) 15mg; calcium (calcium carbonate, calcium hvp chelate, calcium citrate) 166.7mg; iron (iron hvp chelate) 0.667mg; magnesium (magnesium hvp chelate, magnesium oxide, magnesium citrate) 83.33mg; zinc (zinc hvp chelate) 2.5mg; copper (copper hvp chelate) 0.33mg; chromium (chromium hvp chelate) 33.33mcg; manganese (manganese hvp chelate) 0.583mg; iodine (potassium iodide) 0.0125mg; selenium (yeast (living cells)) 16.66mcg; molybdenum (molybdenum citrate) 8.33mcg

United States - English - NLM (National Library of Medicine)

golden state medical supply, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate capsules are a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contains calcium acetate.  animal reproduction studies have not been conducted with calcium acetate capsules, and there are no adequate and well controlled studies of calcium acetate capsules use in pregnant women.  patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] .  maintenance of normal serum calcium levels is important for maternal and fetal well being.  hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism.  calcium acetate capsules treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effec

United States - English - NLM (National Library of Medicine)

nostrum laboratories, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate capsules are a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contains calcium acetate.  animal reproduction studies have not been conducted with calcium acetate capsules, and there are no adequate and well controlled studies of calcium acetate capsules use in pregnant women.  patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] .  maintenance of normal serum calcium levels is important for maternal and fetal well being.  hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism.  calcium acetate capsules treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium a

United States - English - NLM (National Library of Medicine)

state of florida doh central pharmacy - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate gelcaps is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate gelcaps contains calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] . maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are